Introduction
Community-acquired pneumonia (CAP) is contracted outside health facilities and is considered the most important infectious disease encountered in clinical practice. 1, 2 Signs and symptoms include a new infiltrate visible on a chest X-ray with at least two symptoms, such as a cough and sputum production, present. 3 If a patient is suspected to have CAP, a guideline based on the Standard Treatment Guidelines and Essential Medicines List for South Africa is used by public health professionals to determine the course of treatment. 4 The guideline, in the form of an algorithm, states that patients with suspected CAP should undergo chest radiography and their CURB-65 score should be determined. CURB is an acronym for confusion (C), blood urea (U), respiratory rate (R) and systolic blood pressure (B) and is defined as a clinical prediction rule to predict mortality of infection at any state.
5 CURB-65 adds age ≥ 65 years as variable. Patients should be admitted to hospital with a CURB-65 score of ≥ 2. 4 This study aimed to determine the adherence to the treatment guideline by the health professionals treating patients with suspected CAP at National District Hospital (NDH), Bloemfontein.
Methods
The study population for this retrospective descriptive study comprised all patients aged 15-85 years admitted to the medical wards at NDH with suspected CAP from January 2015 to September 2016. Patients were identified from the patient register and information noted from patient files. Patients admitted with CAP to the casualty department only and patients with a suspected hospital-acquired pneumonia were excluded. 
Results
The majority (52.4%) of the 149 patients were female. The patients' mean age was 48.7 years and 85.2% were ≤ 65 years. Table 1 indicates signs and symptoms of patients who were diagnosed with CAP, the tests performed and medications prescribed.
Discussion
Only 60.0% of patients had sputum samples, whereas the guideline requires that a sputum microscopy culture and sensitivity (MC&S) and GeneXpert® (GXP; Cepheid, Sunnyvale, CA, USA)) test should be done for every patient with suspected CAP in order to make a definite diagnosis. 4 Patients were thus mainly treated without knowledge of the specific causative organism, which could lead to prolonged hospitalisation and organism resistance.
Only one of the 149 admitted patients in this study had a noted CURB-65 score that required admission. The guideline states that when a patient has a CURB-65 score < 2 but the doctor still admits the patient, the treatment differs according to the patient's age. For patients < 65 years, the treatment includes penicillin G, amoxicillin and azithromycin. For patients ≥ 65 years, the treatment comprises amoxycillin/clavulanate, ceftriaxone and azithromycin. For patients with CURB-65 scores ≥ 2, the treatment also comprises amoxycillin/clavulanate, ceftriaxone and azithromycin. In all three scenarios, fluoroquinolone is recommended as an alternative. These medications were, however, given to the minority of patients. The use of antibiotics other than those suggested by the guideline may be due to pharmacy stock shortages or clinician suspicion.
Conclusion
The health professionals at NDH did not adhere to the treatment guideline prescribed for the management and treatment of a suspected CAP patient.
Recommendations
Further research is recommended regarding the management approaches used by health professionals at NDH in the treatment of suspected CAP patients.
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